Full Breakdown
Nationwide Recall of Nara Organics Infant Formula After Multi-State Botulism Outbreak
6/19/2026, 9:19:36 PM
Core Event: Recall and Outbreak Overview
The FDA and CDC issued a voluntary nationwide recall of Nara Organics Whole Milk Organic Powdered Infant Formula after epidemiological evidence linked it to three infant botulism cases in California, Pennsylvania and Washington. The infants, aged 2–5 months, were hospitalized, treated with BabyBIG® antitoxin, and have survived. The FDA advises discontinuation, discarding unopened cans, and retaining containers for testing.
Background: Infant Botulism and Product Distribution
Infant botulism is a rare disease caused by ingestion of *Clostridium botulinum* spores that colonize an gut. Symptoms appear 3–30 days after exposure and may include constipation, poor feeding, loss of head control and respiratory difficulty. Nara Organics Whole Milk Organic Infant Formula was sold through Target stores, Target.com and Nara.com from July 2025 to June 2026 in 400-g and 700-g cans.
Timeline of Key Actions
- July 2025–June 2026: Nationwide distribution.
- June 12 2026: FDA contacts Nara Organics, recommends recall.
- June 13 2026: FDA and CDC announce recall.
- June 17 2026: Formal recall notice issued.
- June 19 2026: State health agencies, including Wisconsin DHS, issue advisories.
Official Statements & Responses
The FDA highlighted the outbreak’s severity and the epidemiological signal that prompted recall. The CDC’s Infant Botulism Treatment and Prevention Program urged clinicians to report suspected cases promptly. Wisconsin DHS instructed providers to report infant botulism to its Bureau of Communicable Diseases and advised families to monitor infants for up to one month after exposure. Nara Organics agreed to recall and is processing refunds for purchases made through its website; customers who bought the product elsewhere may request refunds via its site or return the product to Target.
Conflicting Reports & Gaps
Laboratory testing of the formula has not yet identified *C. botulinum* spores, and results from leftover samples collected in two states are pending, leaving a gap in definitive microbiological confirmation.
Verbatim Quotes
- “The FDA warns that symptoms can progress to difficulty breathing and respiratory arrest.” — Food and Drug Administration
- “Infant botulism primarily affects babies younger than six months.” — San Diego County Health Officials
- “All three babies were treated with the botulism antitoxin BabyBIG® and are currently recovering; no deaths have been reported.” — East County Magazine
- “The agency said it contacted the company on June 12 and recommended a recall because of the severity of illness and the outbreak’s epidemiological signal.” — FDA statement reported by Racine County Eye
What’s Next
Testing of retained formula samples is expected within weeks. State health departments will keep heightened surveillance, and clinicians are urged to maintain a high index of suspicion. Families should keep unopened cans for possible testing, clean all contact surfaces with hot, soapy water, and seek refunds through Nara Organics or Target.
